Moreover, despite these potential links between mutant SF3B1 and aberrant heme synthesis, putative targets linking aberrant splicing mediated by SF3B1 mutations and the clonal hematopoiesis that characterizes RARS have not been defined. This evidence concerns the gene SF3B1 and myelodysplastic syndrome with ring sideroblasts.